Advanced Search

MIN Feng-ling, ZHANG Hong. Current Status of Tumor Radiogenic Therapy[J]. Nuclear Physics Review, 2005, 22(2): 219-224. doi: 10.11804/NuclPhysRev.22.02.219
Citation: MIN Feng-ling, ZHANG Hong. Current Status of Tumor Radiogenic Therapy[J]. Nuclear Physics Review, 2005, 22(2): 219-224. doi: 10.11804/NuclPhysRev.22.02.219

Current Status of Tumor Radiogenic Therapy

doi: 10.11804/NuclPhysRev.22.02.219
  • Received Date: 1900-01-01
  • Rev Recd Date: 1900-01-01
  • Publish Date: 2005-06-20
  • Although tumor gene therapy has a distance to clinical use due to some problems, the combination of irradiation and gene therapy holds much promise in cancer therapy based on the traditional radiotherapy, chemotherapy and surgery. We have termed this therapeutic radiogenic therapy. This review focuses on the group of radiogenic therapy that are either: ⑴ improvement of gene transfer efficiency by irradiation; ⑵ radiotherapy combined with cytokines gene delivery or enhancement of the immunity of tumor cells by transgene; ⑶ directly stimulated by radiation to produce either directly or indirectly cytotoxic agents; ⑷ increasing of radiosensitivity in gene therapy; ⑸ radioprotective gene therapyenhances radiation tumor killing effect while protecting the normal tissue and organs with transgene using transfer vector.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2435) PDF downloads(584) Cited by()

Proportional views

Current Status of Tumor Radiogenic Therapy

doi: 10.11804/NuclPhysRev.22.02.219

Abstract: Although tumor gene therapy has a distance to clinical use due to some problems, the combination of irradiation and gene therapy holds much promise in cancer therapy based on the traditional radiotherapy, chemotherapy and surgery. We have termed this therapeutic radiogenic therapy. This review focuses on the group of radiogenic therapy that are either: ⑴ improvement of gene transfer efficiency by irradiation; ⑵ radiotherapy combined with cytokines gene delivery or enhancement of the immunity of tumor cells by transgene; ⑶ directly stimulated by radiation to produce either directly or indirectly cytotoxic agents; ⑷ increasing of radiosensitivity in gene therapy; ⑸ radioprotective gene therapyenhances radiation tumor killing effect while protecting the normal tissue and organs with transgene using transfer vector.

MIN Feng-ling, ZHANG Hong. Current Status of Tumor Radiogenic Therapy[J]. Nuclear Physics Review, 2005, 22(2): 219-224. doi: 10.11804/NuclPhysRev.22.02.219
Citation: MIN Feng-ling, ZHANG Hong. Current Status of Tumor Radiogenic Therapy[J]. Nuclear Physics Review, 2005, 22(2): 219-224. doi: 10.11804/NuclPhysRev.22.02.219

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return